BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32164323)

  • 21. Structural reorganization of alpha-synuclein at low pH observed by NMR and REMD simulations.
    Wu KP; Weinstock DS; Narayanan C; Levy RM; Baum J
    J Mol Biol; 2009 Aug; 391(4):784-96. PubMed ID: 19576220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive atomic resolution descriptions of intrinsically disordered hTau40 and α-synuclein in solution from NMR and small angle scattering.
    Schwalbe M; Ozenne V; Bibow S; Jaremko M; Jaremko L; Gajda M; Jensen MR; Biernat J; Becker S; Mandelkow E; Zweckstetter M; Blackledge M
    Structure; 2014 Feb; 22(2):238-49. PubMed ID: 24361273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tau Interacts with the C-Terminal Region of α-Synuclein, Promoting Formation of Toxic Aggregates with Distinct Molecular Conformations.
    Dasari AKR; Kayed R; Wi S; Lim KH
    Biochemistry; 2019 Jun; 58(25):2814-2821. PubMed ID: 31132261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structures behind the amyloid aggregation of α-synuclein: an NMR based approach.
    Orcellet ML; Fernández CO
    Curr Protein Pept Sci; 2011 May; 12(3):188-204. PubMed ID: 21348834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis.
    Mehra S; Sahay S; Maji SK
    Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):890-908. PubMed ID: 30853581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PreSMo Target-Binding Signatures in Intrinsically Disordered Proteins.
    Kim DH; Han KH
    Mol Cells; 2018 Oct; 41(10):889-899. PubMed ID: 30352491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of Correlated Segment Fluctuations in IDPs upon Complex Formation as an Allosteric Regulatory Mechanism.
    Beier A; Schwarz TC; Kurzbach D; Platzer G; Tribuzio F; Konrat R
    J Mol Biol; 2018 Aug; 430(16):2439-2452. PubMed ID: 29733855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of IDPs with Membranes Using Dark-State Exchange NMR Spectroscopy.
    Das T; Acosta D; Eliezer D
    Methods Mol Biol; 2020; 2141():585-608. PubMed ID: 32696379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic Amyloid Switch Triggered by Early Heterotypic Oligomerization of Intrinsically Disordered α-Synuclein and Tau.
    Bhasne K; Sebastian S; Jain N; Mukhopadhyay S
    J Mol Biol; 2018 Aug; 430(16):2508-2520. PubMed ID: 29704492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry Approach to Correlate Local Structure and Aggregation in α-Synuclein.
    Seetaloo N; Zacharopoulou M; Stephens AD; Kaminski Schierle GS; Phillips JJ
    Anal Chem; 2022 Dec; 94(48):16711-16719. PubMed ID: 36413494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The remarkable conformational plasticity of alpha-synuclein: blessing or curse?
    Deleersnijder A; Gerard M; Debyser Z; Baekelandt V
    Trends Mol Med; 2013 Jun; 19(6):368-77. PubMed ID: 23648364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure and properties of a complex of α-synuclein and a single-domain camelid antibody.
    De Genst EJ; Guilliams T; Wellens J; O'Day EM; Waudby CA; Meehan S; Dumoulin M; Hsu ST; Cremades N; Verschueren KH; Pardon E; Wyns L; Steyaert J; Christodoulou J; Dobson CM
    J Mol Biol; 2010 Sep; 402(2):326-43. PubMed ID: 20620148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial in-cell NMR of human α-synuclein: a disordered monomer by nature?
    Binolfi A; Theillet FX; Selenko P
    Biochem Soc Trans; 2012 Oct; 40(5):950-4. PubMed ID: 22988846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small Molecules Detected by Second-Harmonic Generation Modulate the Conformation of Monomeric α-Synuclein and Reduce Its Aggregation in Cells.
    Moree B; Yin G; Lázaro DF; Munari F; Strohäker T; Giller K; Becker S; Outeiro TF; Zweckstetter M; Salafsky J
    J Biol Chem; 2015 Nov; 290(46):27582-93. PubMed ID: 26396193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vitro Analysis of α-Synuclein Amyloid Formation and Cross-Reactivity.
    Horvath I; Rocha S; Wittung-Stafshede P
    Methods Mol Biol; 2018; 1779():73-83. PubMed ID: 29886528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-cell NMR characterization of the secondary structure populations of a disordered conformation of α-synuclein within E. coli cells.
    Waudby CA; Camilloni C; Fitzpatrick AW; Cabrita LD; Dobson CM; Vendruscolo M; Christodoulou J
    PLoS One; 2013; 8(8):e72286. PubMed ID: 23991082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probing the micelle-bound aggregation-prone state of α-synuclein with (19)F NMR spectroscopy.
    Wang GF; Li C; Pielak GJ
    Chembiochem; 2010 Sep; 11(14):1993-6. PubMed ID: 20730847
    [No Abstract]   [Full Text] [Related]  

  • 38. Unveiling transient protein-protein interactions that modulate inhibition of alpha-synuclein aggregation by beta-synuclein, a pre-synaptic protein that co-localizes with alpha-synuclein.
    Janowska MK; Wu KP; Baum J
    Sci Rep; 2015 Oct; 5():15164. PubMed ID: 26477939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction between Copper Chaperone Atox1 and Parkinson's Disease Protein α-Synuclein Includes Metal-Binding Sites and Occurs in Living Cells.
    Horvath I; Blockhuys S; Šulskis D; Holgersson S; Kumar R; Burmann BM; Wittung-Stafshede P
    ACS Chem Neurosci; 2019 Nov; 10(11):4659-4668. PubMed ID: 31600047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-fibrillation potency of caffeic acid against an antidepressant induced fibrillogenesis of human α-synuclein: Implications for Parkinson's disease.
    Fazili NA; Naeem A
    Biochimie; 2015 Jan; 108():178-85. PubMed ID: 25461276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.